Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Allergy & Immunology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Bimekizumab Shows Durable Long-Term Psoriasis Clearance
January 2026
Researchers identified a distinct population of tissue-resident memory T (TRM) cells expressing IL-17A and/or IL-17F that were largely absent from healthy skin.
Read more
30 Jan 2026
Bimekizumab Shows Durable Long-Term Psoriasis Clearance
Researchers identified a distinct population of tissue-resident memory T (TRM) cells expressing IL-17A and/or IL-17F that were largely absent from healthy skin.
24 Jan 2026
Breastfeeding Linked to Lower Asthma Risk
Exclusive breastfeeding for at least four months was associated with lower overall odds of asthma up to age 24 years (odds ratio: 0.75; 95% CI: 0.64–0.87).
22 Jan 2026
New Asthma Drug Shows Promise in First Human Study
Londamocitinib produced approximately 50% reductions in fractional exhaled nitric oxide at the 1.4 mg and 3 mg doses.
17 Jan 2026
Early Bifidobacteria Colonisation Reduces Childhood Allergy Risk
Importantly, this microbiota–metabolite signature was inversely associated with the development of food allergen-specific IgE up to 5 years of age and with atopic dermatitis at 2 years.
15 Jan 2026
ALA-DAG Oil Improves Skin Hydration and Allergy Symptoms
ALA-DAG oil improved skin hydration and reduced allergic symptoms in adults with mild skin discomfort.
10 Jan 2026
Low-Dose Peanut Oral Immunotherapy Shows Promise
After 1 year, 13 of 17 patients in the 30 mg group tolerated at least 443 mg peanut protein, compared with none in the avoidance group. Similar improvements were observed in the 300 mg group.
8 Jan 2026
Autoclaving Dramatically Reduces Peanut Allergenicity and Improves Tolerability
Autoclaving peanuts significantly reduces IgE binding and improves tolerability in peanut-allergic individuals, offering promise for safer immunotherapy approaches.
4 Jan 2026
Basophil Activation Test Promising for Predicting Severity of Cow’s Milk Allergy
The basophil activation test may help identify children at risk of severe allergic reactions to cow’s milk, improving safety during oral food challenges.
Loading posts...
1
2
3
…
40
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View